Methamphetamine Use Disorder Clinical Trials

42 clinical trials for Methamphetamine Use Disorder across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder — RECRUITING · NA
• Non-Abstinence Outcomes in Methamphetamine Use Disorder — RECRUITING · NA
• Methamphetamine and Troriluzole — RECRUITING · PHASE1
• LDART for Stimulant Use Disorder — RECRUITING · NA
• Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii — RECRUITING · NA
• ECG Findings in Methamphetamine Use — RECRUITING
• A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder — RECRUITING · NA
• LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis — RECRUITING
• Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder — RECRUITING · PHASE2
• Psilocybin for Methamphetamine Addiction — RECRUITING · PHASE1
• Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder — RECRUITING · NA
• Deep TMS of Neural Circuits Associated With Stimulant Use Disorder — RECRUITING · NA
• Methamphetamine Cue-reactivity — RECRUITING
• EXPLORING FEASIBILITY AND ACCEPTABILITY OF PROLONGED ADMINISTRATION OF HIGHDOSE STIMULANTS IN PEOPLE WITH METHAMPHETAMINE USE DISORDER: AN EXTENSION OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL — RECRUITING
• ADDITION OF HIGH DOSE STIMULANT AND ENGAGEMENT-FOCUSED CONTINGENCY MANAGEMENT, ALONE AND IN COMBINATION, TO TREATMENT AS USUAL FOR THE MANAGEMENT OF METHAMPHETAMINE USE DISORDER (ASCME): A PAN-CANADIAN MULTI-CENTRE,RANDOMIZED, CONTROLLED TRIAL — RECRUITING
• Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV — COMPLETED · PHASE2
• Psilocybin Therapy for Methamphetamine Use Disorder and HIV — NOT_YET_RECRUITING · PHASE2
• An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder — NOT_YET_RECRUITING · PHASE2
• Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study — NOT_YET_RECRUITING · PHASE2
• Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder — TERMINATED · PHASE1
• Methamphetamine Use Disorder Support in Heart Failure Pilot Study — NOT_YET_RECRUITING · NA
• α-N-acetylgalactosaminidase in Methamphetamine Psychosis — COMPLETED
• Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia — COMPLETED · NA
• Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization — NOT_YET_RECRUITING · NA
• Beginning Early and Assertive Treatment for Methamphetamine Use Disorder — COMPLETED · NA
• Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM — COMPLETED · PHASE2
• CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM — NOT_YET_RECRUITING · NA
• Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics — ACTIVE_NOT_RECRUITING · NA
• A Telephone-delievered Intervention to Reduce Methamphetamine Use — COMPLETED · NA
• rTMS for Stimulant Use Disorders — COMPLETED · NA
• Tirzepatide for Obesity and Meth Use Disorder — ACTIVE_NOT_RECRUITING · PHASE2
• Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder — ACTIVE_NOT_RECRUITING · PHASE1
• The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder — TERMINATED · PHASE2
• Intranasal Oxytocin for Methamphetamine Withdrawal in Women — COMPLETED · NA
• Mirtazapine and Methamphetamine Drug-drug Interaction Study — COMPLETED · PHASE1
• TACS Intervention for Methamphetamine Addiction — ACTIVE_NOT_RECRUITING · NA
• A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment — OTHER · NA
• Bupropion in the Treatment of Methamphetamine Dependence — COMPLETED · NA
• Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine] — COMPLETED · PHASE1
• Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder — COMPLETED · PHASE3
• Study of Pomaglumetad and Methamphetamine — TERMINATED · PHASE1
• Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder — COMPLETED · PHASE1

Refine this search